Primary prevention of cardiovascular disease: managing hypertension and hyperlipidaemia

被引:6
|
作者
Hobbs, FDR [1 ]
机构
[1] Univ Birmingham, Sch Med, Birmingham B15 2TT, W Midlands, England
关键词
D O I
10.1136/hrt.2004.037580
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular medicine has a sound evidence base upon which health professionals can base their interventions to modify risk among the British public. For primary prevention of cardiovascular disease, however, while there is considerable evidence on what to do, data are limited on how the evidence should be implemented in practice. The challenge will be to learn by experience which interventions directed at reducing blood pressure and lipids levels work best in different settings. There is a need to structure care to identify individuals who are at risk. Current targets are explicit and achievable for both hypertension and lipids. Effective treatment is likely to require multiple drug treatment.
引用
收藏
页码:22 / 25
页数:4
相关论文
共 50 条
  • [41] Statins for primary prevention of cardiovascular disease
    Byrne, Paula
    Cullinan, John
    Smith, Susan M.
    BMJ-BRITISH MEDICAL JOURNAL, 2019, 367
  • [42] Statins for primary prevention of cardiovascular disease
    Otto, Catherine M.
    HEART, 2017, 103 (07) : 477 - 478
  • [43] Statins for primary prevention of cardiovascular disease
    French, Louise
    AUSTRALIAN PRESCRIBER, 2012, 35 (03) : 77 - 77
  • [44] Aspirin for primary prevention of cardiovascular disease
    Waltering, A
    Hemkens, L
    Florack, C
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2005, 130 (49) : 2847 - 2852
  • [45] Yoga for the primary prevention of cardiovascular disease
    Hartley, Louise
    Dyakova, Mariana
    Holmes, Jennifer
    Clarke, Aileen
    Lee, Myeong Soo
    Ernst, Edzard
    Rees, Karen
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (05):
  • [46] Statins for primary prevention of cardiovascular disease
    Otto, Catherine M.
    BMJ-BRITISH MEDICAL JOURNAL, 2016, 355
  • [47] Aspirin for primary prevention of cardiovascular disease
    Gelbenegger, G.
    Postula, M.
    Pecen, L.
    Halvorsen, S.
    Lesiak, M.
    Schoergenhofer, C.
    Jilma, B.
    Hengstenberg, C.
    Siller-Matula, J. M.
    EUROPEAN HEART JOURNAL, 2019, 40 : 276 - 276
  • [48] Hyperlipidaemia and cardiovascular disease - Newer antihyperglycaemic agents and cardiovascular disease
    Peter, Rajesh
    Bajwa, Hammad
    Anthony, Sony
    CURRENT OPINION IN LIPIDOLOGY, 2013, 24 (02) : 189 - 190
  • [49] Primary prevention strategies for cardiovascular disease
    Tyerman, G
    Tyerman, P
    Roscoe, TJ
    BRITISH MEDICAL JOURNAL, 2002, 325 (7370): : 969 - 969
  • [50] Polypills for primary prevention of cardiovascular disease
    Clara K. Chow
    Qingtao Meng
    Nature Reviews Cardiology, 2019, 16 : 602 - 611